Showing results (11-20 of 678) with videos related to
Sort By:
Pageof 68
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 21, 2015
Multiple myeloma: from front-line to relapsed therapiesPhilippe Moreau, Cyrille TouzeauExpert Opinion on Drug Safety|June 30, 2017
Safety of ixazomib for the treatment of multiple myelomaAntoine Bonnet, Philippe MoreauFuture Oncology (London, England)|February 23, 2018
Ixazomib in the management of relapsed multiple myelomaCyrille Touzeau, Philippe MoreauFuture Oncology (London, England)|June 20, 2014
Elotuzumab for the treatment of multiple myelomaPhilippe Moreau, Cyrille TouzeauBlood|April 11, 2022
T-cell-redirecting bispecific antibodies in multiple myeloma: a revolution?Philippe Moreau, Cyrille TouzeauBlood Cancer Discovery|September 16, 2025
Perspectives on Newly Diagnosed Myeloma Treatment and Emerging ChallengesCyrille Touzeau, Philippe MoreauAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Global Approaches in Myeloma: Critical Trials That May Change PracticePhilippe Moreau, Cyrille TouzeauHematology. American Society of Hematology. Education Program|February 20, 2015
All transplantation-eligible patients with myeloma should receive ASCT in first responsePhilippe Moreau, Michel AttalSeminars in Oncology|October 19, 2013
Initial treatment of transplant candidates with multiple myelomaPhilippe Moreau, Cyrille TouzeauPageof 68